A cannabidiol oil study authorized by the Nebraska Legislature in 2015 has shown the majority of 23 patients in the study have benefited from the cannabis derivative.
Patients in the study were ones diagnosed with intractable or treatment-resistant seizures.
The study was authorized by a bill (LB390) introduced by Sen. Sue Crawford of Bellevue, and was passed the same year a bill (LB643), introduced by Sen. Tommy Garrett of Bellevue, got through a first round of debate, then was withdrawn at the end of the session by its sponsor.
Garrett's bill would have legalized medical cannabis for a variety of illnesses and conditions. While a medical cannabis bill has been introduced in most sessions since then, it has not moved successfully through three rounds of debate.
Top photo courtesy of Adobe Stock
